NSB 2.56% 3.8¢ neuroscientific biopharmaceuticals ltd

Ann: Positive results in biomarker characterisation of Emtins, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 348 Posts.
    lightbulb Created with Sketch. 62
    Need to have more peptides in the pipeline after they sell the licence for EmtinB to big pharma for $500xmillion.0

    no point in putting all their eggs in one basket.

 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.